Kempner Capital Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-68,361
Closed -$1.42M 54
2024
Q2
$1.42M Hold
68,361
0.75% 39
2024
Q1
$1.28M Sell
68,361
-5
-0% -$86 0.7% 39
2023
Q4
$986K Sell
68,366
-33,732
-33% -$459K 0.55% 43
2023
Q3
$1.77M Hold
102,098
1.07% 38
2023
Q2
$2.13M Hold
102,098
1.36% 30
2023
Q1
$2.4M Hold
102,098
1.4% 31
2022
Q4
$2.85M Sell
102,098
-552
-0.5% -$14.1K 1.73% 28
2022
Q3
$2.4M Buy
102,650
+18,924
+23% +$571K 1.59% 28
2022
Q2
$2.83M Sell
83,726
-2,275
-3% -$79.7K 1.72% 29
2022
Q1
$3M Sell
86,001
-81,381
-49% -$2.78M 1.65% 29
2021
Q4
$5.1M Sell
167,382
-491
-0.3% -$16K 3% 12
2021
Q3
$5.5M Hold
167,873
3.14% 12
2021
Q2
$5.08M Buy
+167,873
New +$5.53M 2.88% 12

Other funds holding OGN

Kempner Capital Management's OGN Position: Q3 2024 in Review

Kempner Capital Management sold out of Organon & Co (OGN) in Q3 2024, closing a stake of 68,361 shares — an estimated $1.42M sold.

Kempner Capital Management first reported a position in OGN in Q2 2021 and held it in 13 quarters. The position peaked at $5.5M in Q3 2021. 724 funds tracked by Wall St. Rank hold OGN as of Q3 2024.

  • Kempner Capital Management reported no remaining Organon & Co position as of Q3 2024 after selling out during the quarter.
  • Kempner Capital Management sold 68,361 Organon & Co shares in Q3 2024, an estimated $1.42M.
  • Kempner Capital Management first reported a position in Organon & Co in Q2 2021 and held it in 13 quarters.
  • Kempner Capital Management's Organon & Co position peaked at $5.5M in Q3 2021.
  • 724 funds tracked by Wall St. Rank held Organon & Co as of Q3 2024.

Based on Kempner Capital Management's 13F filing for Q3 2024, filed 21 Oct 2024.